Plavix Patent Trial Delayed
A trial over patent rights to Sanofi-Synthélabo's best-selling blood-thinning drug Plavix has been delayed until next year, leaving a shadow over the French pharmaceutical company....To view the full article, register now.
Already a subscriber? Click here to view full article